These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33683014)

  • 1. Trends in the prenatal diagnosis of trisomy 21 show younger maternal age and shift in the distribution of congenital heart disease over a 20-year period.
    Tidrenczel Z; Hajdu J; Simonyi A; Szabó I; Ács N; Demeter J; Beke A
    Am J Med Genet A; 2021 Jun; 185(6):1732-1742. PubMed ID: 33683014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prenatal diagnosis of associated congenital heart diseases by fetal ultrasonographic examination in Europe.
    Stoll C; Garne E; Clementi M;
    Prenat Diagn; 2001 Apr; 21(4):243-52. PubMed ID: 11288111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal detection of structural cardiac defects and presence of associated anomalies: a retrospective observational study of 1262 fetal echocardiograms.
    Mone F; Walsh C; Mulcahy C; McMahon CJ; Farrell S; MacTiernan A; Segurado R; Mahony R; Higgins S; Carroll S; McParland P; McAuliffe FM
    Prenat Diagn; 2015 Jun; 35(6):577-82. PubMed ID: 25663276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal diagnosis of heart defects and associated chromosomal aberrations].
    Chaoui R; Körner H; Bommer C; Göldner B; Bierlich A; Bollmann R
    Ultraschall Med; 1999 Oct; 20(5):177-84. PubMed ID: 10595385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between prenatal atrioventricular septal defects and chromosomal abnormalities.
    Morlando M; Bhide A; Familiari A; Khalil A; Morales-Roselló J; Papageorghiou AT; Carvalho JS
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():31-35. PubMed ID: 27888703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between congenital heart disease and Down syndrome in prenatal life.
    Paladini D; Tartaglione A; Agangi A; Teodoro A; Forleo F; Borghese A; Martinelli P
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):104-8. PubMed ID: 10775990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracardiac lesions and chromosomal abnormalities associated with major fetal heart defects: comparison of intrauterine, postnatal and postmortem diagnoses.
    Song MS; Hu A; Dyamenahalli U; Chitayat D; Winsor EJ; Ryan G; Smallhorn J; Barrett J; Yoo SJ; Hornberger LK
    Ultrasound Obstet Gynecol; 2009 May; 33(5):552-9. PubMed ID: 19350566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results.
    Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
    Am J Med Genet A; 2008 Oct; 146A(19):2455-67. PubMed ID: 18785270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does First-Trimester Screening Modify the Natural History of Congenital Heart Disease? Analysis of Outcome of Regional Cardiac Screening at 2 Different Time Periods.
    Jicinska H; Vlasin P; Jicinsky M; Grochova I; Tomek V; Volaufova J; Skovranek J; Marek J
    Circulation; 2017 Mar; 135(11):1045-1055. PubMed ID: 28143885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study.
    Tennstedt C; Chaoui R; Körner H; Dietel M
    Heart; 1999 Jul; 82(1):34-9. PubMed ID: 10377306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of ultrasound markers in screening fetal trisomy 21].
    Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis.
    Borruto F; Comparetto C; Acanfora L; Bertini G; Rubaltelli FF
    Clin Exp Obstet Gynecol; 2002; 29(4):235-41. PubMed ID: 12635737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of congenital heart disease in the Naples area during the years 1994-1999 -- the experience of a joint fetal-pediatric cardiology unit.
    Paladini D; Russo M; Teodoro A; Pacileo G; Capozzi G; Martinelli P; Nappi C; Calabrò R
    Prenat Diagn; 2002 Jul; 22(7):545-52. PubMed ID: 12124685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal detection of heart defects as an indication for chromosome analysis.
    Schwanitz G; Zerres K; Gembruch U; Bald R; Gamerdinger F; Hansmann M
    Ann Genet; 1990; 33(2):79-83. PubMed ID: 2146918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant right subclavian artery: incidence and correlation with other markers of Down syndrome in second-trimester fetuses.
    Paladini D; Sglavo G; Pastore G; Masucci A; D'Armiento MR; Nappi C
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):191-5. PubMed ID: 21793087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant right subclavian artery as a new cardiac sign in second- and third-trimester fetuses with Down syndrome.
    Chaoui R; Heling KS; Sarioglu N; Schwabe M; Dankof A; Bollmann R
    Am J Obstet Gynecol; 2005 Jan; 192(1):257-63. PubMed ID: 15672034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the prenatal screening mode for fetal congenital heart diseases by ultrasound].
    Ren YY; Li XT; Gui YH; Yan YL; Chang C; Zhang JH; Sun L; Zhou YQ; Kong FB; Zhao W
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):589-92. PubMed ID: 19087493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
    Yang Y; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Atrioventricular Septal Defect (AVSD) as a planned congenital heart disease with different outcome depending on the presence of the coexisting extracardiac abnormalities (ECA) and/or malformations (ECM).
    Słodki M; Soroka M; Rizzo G; Respondek-Liberska M;
    J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2635-2641. PubMed ID: 30514144
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of fetal echocardiography in genetic sonography.
    DeVore GR
    Semin Perinatol; 2003 Apr; 27(2):160-72. PubMed ID: 12769202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.